BRIACELL THERAPEUTICS CORP's ticker is BCTXW and the CUSIP is 10778Y112. A total of 9 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $19,000 | – | 10,445 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 209,540 | $377,000 | 0.09% |
| Murchinson Ltd. | 100,000 | $180,000 | 0.06% |
| Redmond Asset Management, LLC | 75,000 | $135,000 | 0.04% |
| ARMISTICE CAPITAL, LLC | 375,000 | $675,000 | 0.01% |
| Warberg Asset Management LLC | 32,000 | $58,000 | 0.01% |
| ZEKE CAPITAL ADVISORS, LLC | 45,000 | $81,000 | 0.01% |
| Intellectus Partners, LLC | 10,000 | $18,000 | 0.00% |
| Virtu Financial LLC | 10,445 | $19,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 10,181 | $18,000 | 0.00% |